Fig. 3.
Representative ve maps of groups 1–4 before dosing (day 0) or 3 days posttherapy (day 3) in a a whole tumor region or b peripheral tumor region with a constant scale (from 0 to 0.7). c, d ve changes of the four groups during 3 days posttherapy in c whole tumor region or d peripheral tumor region. Different Greek letters present statistical differences among groups during 3 days.
